Imovax Polio

Imovax Polio

vaccine, poliomyelitis


Sanofi Pasteur


Concise Prescribing Info
Inactivated types 1,2,3 poliomyelitis vaccine: Type 1 (Mahoney) 40 DU, type 2 (MEF-I) 8 DU, type 3 (Saukett) 32 DU
Prevention of poliomyelitis in infants, childn & adults for primary vaccination & booster.
Dosage/Direction for Use
IM/SC Non-vaccinated adult 2 successive 0.5 mL inj at interval of 2 mth, followed by a booster dose 8-12 mth after the 1st inj. Childn 1 dose at the age of 2 mth & 1 dose at the age of 4 mth, followed by a booster dose at the age of 11 mth.
Hypersensitivity to poliomyelitis vaccine, neomycin, streptomycin, polymyxin B. Postpone vaccination in case of fever or acute disease.
Special Precautions
Blood disorders eg, thrombocytopenia or clotting disorder; taking treatment that suppresses immune defences or presenting w/ an immune deficiency disorder (postpone vaccination). Present w/ chronic immunodeficiency eg, infection w/ AIDS virus (HIV). Do not inj intravascularly.
Adverse Reactions
Inj site pain, fever (≥38.1°C). Inj site redness.
ATC Classification
J07BF03 - poliomyelitis, trivalent, inactivated, whole virus ; Belongs to the class of poliomyelitis viral vaccines.
Imovax Polio inj
(multidose vial) 0.5 mL x 1's (P420/vial); (pre-filled syringe) 0.5 mL x 1's (P350/pre-filled syringe)
/philippines/image/info/imovax polio inj/0-5 ml?id=76ae5d91-1a50-4f84-b800-a6480115b24a
/philippines/image/info/imovax polio inj/0-5 ml?id=5cd8aee9-4a66-4868-b7e1-9faa00d277c3
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in